Adaptive Biotechnologies (ADPT) Treasury Shares (2019 - 2026)

Adaptive Biotechnologies has disclosed Treasury Shares across 8 years of filings, most recently posting $4.5 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $4.5 million, down 15.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (down 15.21% YoY), and the FY2025 annual result was $11.2 million, up 10.52% from the prior year.
• Treasury Shares came in at $4.5 million for Q1 2026 at Adaptive Biotechnologies, down from $11.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $12.0 million in Q1 2024 to a low of $1.9 million in Q2 2024.
• The 5-year median for Treasury Shares is $5.6 million (2022), against an average of $7.2 million.
• Across the five-year window, Treasury Shares jumped 742.56% in 2022 and tumbled 82.17% in 2024, its largest moves.
• Adaptive Biotechnologies' Treasury Shares stood at $6.0 million in 2022, then jumped by 61.65% to $9.7 million in 2023, then climbed by 5.23% to $10.2 million in 2024, then increased by 10.52% to $11.2 million in 2025, then slumped by 59.61% to $4.5 million in 2026.
• The last three Treasury Shares figures came in at $4.5 million (Q1 2026), $11.2 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.